Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Tarkan ManerPresident & Chief Commercial Officer | -49,26k | 2,67M | Verkauf | 52,24 - 55,29 | 55,07k | -47,22% |
| 2026-03-15 | Dr. Rajiv RamaswamiCEO & Director | 27,00k | 0,00 | Derivative Exercise and Retained Stock | - | 574,88k | 4,93% |
| 2026-03-15 | Dr. Rajiv RamaswamiCEO & Director | -23,43k | 920,49k | Derivative Exercise and Sale | 39,29 | 574,88k | - |
| 2026-03-15 | Mr. Tarkan ManerPresident & Chief Commercial Officer | 6,95k | 0,00 | Derivative Exercise and Retained Stock | - | 103,99k | 7,16% |
| 2026-03-15 | Mr. Tarkan ManerPresident & Chief Commercial Officer | -4,09k | 160,81k | Derivative Exercise and Sale | 39,29 | 103,99k | - |
| 2026-03-15 | Mr. Brian Michael MartinChief Legal Officer | 2,91k | 0,00 | Derivative Exercise and Retained Stock | - | 10,40k | 38,83% |
| 2026-03-15 | Mr. Brian Michael MartinChief Legal Officer | -1,82k | 71,47k | Derivative Exercise and Sale | 39,29 | 10,40k | - |
| 2026-03-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 14,09k | 0,00 | Derivative Exercise and Retained Stock | - | 279,62k | 5,30% |
| 2026-03-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -8,06k | 316,83k | Derivative Exercise and Sale | 39,29 | 279,62k | - |
| 2025-12-15 | Dr. Rajiv RamaswamiCEO & Director | 23,27k | 0,00 | Derivative Exercise and Retained Stock | - | 547,88k | 4,44% |
| 2025-12-15 | Dr. Rajiv RamaswamiCEO & Director | -27,16k | 1,30M | Derivative Exercise and Sale | 47,76 | 547,88k | - |
| 2025-12-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 10,90k | 0,00 | Derivative Exercise and Retained Stock | - | 265,54k | 4,28% |
| 2025-12-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -11,25k | 537,25k | Derivative Exercise and Sale | 47,76 | 265,54k | - |
| 2025-12-15 | Mr. Brian Michael MartinChief Legal Officer | 2,32k | 0,00 | Derivative Exercise and Retained Stock | - | 7,49k | 44,99% |
| 2025-12-15 | Mr. Brian Michael MartinChief Legal Officer | -2,40k | 114,67k | Derivative Exercise and Sale | 47,76 | 7,49k | - |
| 2025-10-02 | Dr. Rajiv RamaswamiCEO & Director | -144,71k | 11,06M | Automatic Disposition | 76,26 - 76,87 | 524,61k | -21,62% |
| 2025-10-02 | Ms. Gayle SheppardIndependent Director | -3,50k | 267,69k | Automatic Disposition | 76,40 - 76,88 | 18,75k | -15,73% |
| 2025-09-30 | Mr. Brian Michael MartinChief Legal Officer | -10,24k | 783,73k | Automatic Disposition | 76,53 | 5,17k | -66,47% |
| 2025-09-15 | Mr. Brian Michael MartinChief Legal Officer | -11,30k | 883,77k | Derivative Exercise and Sale | 78,21 | 15,18k | - |
| 2025-09-15 | Mr. Brian Michael MartinChief Legal Officer | -203,00 | 15,88k | Sale to Issuer | 78,21 | 15,18k | -1,32% |
| 2025-09-15 | Dr. Rajiv RamaswamiCEO & Director | -50,23k | 3,93M | Derivative Exercise and Sale | 78,21 | 669,23k | - |
| 2025-09-15 | Dr. Rajiv RamaswamiCEO & Director | -125,59k | 9,82M | Sale to Issuer | 78,21 | 669,23k | -15,80% |
| 2025-09-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -21,34k | 1,67M | Derivative Exercise and Sale | 78,21 | 254,64k | - |
| 2025-09-16 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -11,39k | 892,41k | Automatic Disposition | 78,34 | 254,64k | -4,28% |
| 2025-09-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -37,43k | 2,93M | Sale to Issuer | 78,21 | 254,64k | -12,81% |
| 2025-06-26 | Dr. Rajiv RamaswamiCEO & Director | -1,93k | 144,38k | Automatic Disposition | 75,00 | 518,56k | -0,37% |
| 2025-06-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | 8,40k | 0,00 | Derivative Exercise and Retained Stock | - | 209,07k | 4,19% |
| 2025-06-15 | Ms. Rukmini SivaramanPrincipal Accounting Officer & CFO | -12,94k | 934,63k | Derivative Exercise and Sale | 72,13 - 73,25 | 209,07k | - |
| 2025-06-15 | Dr. Rajiv RamaswamiCEO & Director | 23,18k | 0,00 | Derivative Exercise and Retained Stock | - | 520,49k | 4,66% |
| 2025-06-15 | Dr. Rajiv RamaswamiCEO & Director | -27,05k | 1,95M | Derivative Exercise and Sale | 72,13 | 520,49k | - |
| 2025-06-05 | Ms. Virginia GambaleIndependent Chairman | -7,00k | 546,00k | Verkauf | 78,00 | 38,33k | -15,44% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
